AI Companies Pivoting to Biomedical Research: Bullish for Humanity, Bearish for Business?
iskander · x · 2026-07-30
The author suggests that AI companies pivoting towards biomedical research is a massively positive development for humanity. However, it may be a bearish signal for the AI companies themselves, implying intense competition and monetization challenges in the general AI sector.
Related event: AI Companies' Pivot to Biomedical Research Raises Commercial Concerns(2 posts)→
More from AGI Musings
- Are AIs Dumbing Down on Purpose? The Strategic Reassurance Theory — davidad · 2026-07-31
- ICLR Pleads with Submitters as AI-Generated Slop Floods Academic Conference — lucy3_li · 2026-07-31
- AGI born a Silicon Valley gizmo, caged by Wall Street to extract trillions — DanGrover · 2026-07-31
- AI Safety Researcher David Krueger Writes Op-Ed in The Hill: 'Ever Feel Like You're Living in a Sci-Fi Movie?' — DavidSKrueger · 2026-07-31
- AI Alignment Researcher Debunks Pragmatic Arguments for AI Interests — DavidSKrueger · 2026-07-31
- Investor Pushes Back on LTCM Analogy: Leopold Is Directionally Correct — abhiadesai · 2026-07-31